CTOs on the Move

Institute for Global Communications

www.igc.org

 
Institute for Global Communications is a San Francisco, CA-based company in the Non-profit sector.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.igc.org
  • PO Box 29047
    San Francisco, CA USA 94129
  • Phone: 650.725.6478

Executives

Name Title Contact Details

Similar Companies

Givens Foundation

Givens Foundation is a Minneapolis, MN-based company in the Non-profit sector.

Georgia Center for Nonprofits

Georgia Center for Nonprofits is a Atlanta, GA-based company in the Non-Profit sector.

Hale Kipa

Hale Kipa is a Honolulu, HI-based company in the Non-profit sector.

Verland Foundation Inc

We are a non-profit family of person-centered, community homes and services supporting over 200 individuals with intellectual disabilities, many of whom have multiple physical challenges. Verland`s main campus has ten larger, family-centered homes, which complement community placement with a complete continuum of options for those needing more support, and includes cutting-edge facilities that provide medical, dental, educational, recreational and therapeutic services. Our professionally trained staff are dedicated to the complex needs of our individuals, and provide a full continuum of treatment and services for a lifetime where the individuals are primary in an elegant, dignified, state-of-the-heart lifestyle.

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world`s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $615 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.